Literature DB >> 24820800

[Acute generalized exanthematous pustulosis].

A Sidoroff1.   

Abstract

CLINICAL FEATURES: Acute generalized exanthematous pustulosis (AGEP) is a reaction pattern mostly caused by drugs. It is characterized by the rapid occurrence of dozens to thousands pinhead-sized, non-follicular, sterile pustules on a slightly edematous erythematous base, commonly with accentuation in the major flexures and usually accompanied by a facial edema, fever and leukocytosis. Histology reveals spongiform subcorneal and/or intraepidermal pustules, an inflammatory infiltrate consisting of neutrophils and often eosinophils and frequently a marked edema of the papillary dermis. TRIGGERS: Even if in single case reports a large number of drugs has been described as triggers for AGEP, larger studies have revealed a list with an elevated risk to cause the reaction which includes antibacterial agents like ampicillin/amoxicillin, quinolones, pristinamycin, anti-infective sulfonamides, the antimycotic drug terbinafine, (hydroxy)chloroquine, and diltiazem. In some cases infections have been reported as triggers. CLINICAL COURSE, PROGNOSIS AND TREATMENT: AGEP is an acute and--especially in patients with concomitant diseases--sometimes severe reaction. Withdrawal of the causative agent usually leads to a rapid and complete resolution--even without further specific therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24820800     DOI: 10.1007/s00105-013-2698-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  31 in total

1.  Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation.

Authors:  Simone Schmid; Petra C Kuechler; Markus Britschgi; Urs C Steiner; Nikhil Yawalkar; Alain Limat; Kurt Baltensperger; Lasse Braathen; Werner J Pichler
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Acute generalized exanthematous pustulosis (AGEP) induced by terbinafine with involuntary positive reintroduction.

Authors:  M Gréco; P Plantin
Journal:  Eur J Dermatol       Date:  2005 Mar-Apr       Impact factor: 3.328

3.  Generalized pustular drug eruptions: confirmation by in vitro tests.

Authors:  A Lazarov; E Livni; S Halevy
Journal:  J Eur Acad Dermatol Venereol       Date:  1998-01       Impact factor: 6.166

4.  Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis.

Authors:  Alexander A Navarini; Laurence Valeyrie-Allanore; Niovi Setta-Kaffetzi; Jonathan N Barker; Francesca Capon; Daniel Creamer; Jean-Claude Roujeau; Peggy Sekula; Michael A Simpson; Richard C Trembath; Maja Mockenhaupt; Catherine H Smith
Journal:  J Invest Dermatol       Date:  2013-01-28       Impact factor: 8.551

5.  Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases.

Authors:  H Baker; T J Ryan
Journal:  Br J Dermatol       Date:  1968-12       Impact factor: 9.302

6.  T-cell involvement in drug-induced acute generalized exanthematous pustulosis.

Authors:  M Britschgi; U C Steiner; S Schmid; J P Depta; G Senti; A Bircher; C Burkhart; N Yawalkar; W J Pichler
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

7.  The spectrum of histopathological features in acute generalized exanthematous pustulosis: a study of 102 cases.

Authors:  S Halevy; S H Kardaun; B Davidovici; J Wechsler
Journal:  Br J Dermatol       Date:  2010-12       Impact factor: 9.302

Review 8.  Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells.

Authors:  Markus Britschgi; Werner J Pichler
Journal:  Curr Opin Allergy Clin Immunol       Date:  2002-08

9.  Pustular drug eruptions: a histopathological spectrum.

Authors:  N P Burrows; R R Russell Jones
Journal:  Histopathology       Date:  1993-06       Impact factor: 5.087

Review 10.  [Drugs associated with acute generalized exanthematic pustulosis].

Authors:  E-H Saissi; F Beau-Salinas; A-P Jonville-Béra; G Lorette; E Autret-Leca
Journal:  Ann Dermatol Venereol       Date:  2003 Jun-Jul       Impact factor: 0.777

View more
  3 in total

Review 1.  [Terbinafine : Drug-induced lupus erythematodes and triggering of psoriatic skin lesions].

Authors:  P Mayser
Journal:  Hautarzt       Date:  2016-09       Impact factor: 0.751

2.  Allergic Maculo-Papular Exanthema Due To Terbinafine.

Authors:  André Koch; Georgi Tchernev; Uwe Wollina
Journal:  Open Access Maced J Med Sci       Date:  2017-07-20

3.  Cephalexin-induced acute generalized exanthematous pustulosis.

Authors:  Matthew DaCunha; Sarah Moore; David Kaplan
Journal:  Dermatol Reports       Date:  2018-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.